Hikma Pharmaceuticals USA v Amarin Pharma presents a complex dispute between Amarin, the manufacturer of Vascepa, a ...

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...

The U.S. Supreme Court will hear a case that could clarify when generic drug makers are liable for patent infringement tied ...

This article was produced in partnership with The New York Times. Not all drug prices are going up. Amid the public fury over the escalating costs of brand-name medications, the prices of generic ...

Forbes contributors publish independent expert analyses and insights. I am a physician and behavioral scientist at Duke University. Brand-name chemotherapy is often incredibly expensive, in excess of ...

INDIANAPOLIS — When you are out shopping, you often see labels showing where the product is made. But look at your generic medication and there is a good chance the "made in" line is missing. Dr.

The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...

From a more affordable diabetes drug to a surprising cancer connection at home, here's what's making health headlines today.

Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms are ...

SNiP Nutrigenomics analyzes 103 genetic markers to create custom supplement formulas, replacing guesswork with DNA-driven ...